← Back to Stock Screener← Stock Screener

ZYBERNO

Stock Report

Updated Aug 31, 2026

Enovis Corp (ENOV)

Healthcare • NYSE

$24.90

Professional Investment Analysis

ZYBERNO SCORE →

Is it a great business? Is it getting better?

26.0/100

POOR BUSINESS

Enovis Corp (ENOV) scores 26/100 — concerning metrics indicating significant structural or financial risks.

📊 How is the Zyberno Score calculated? +

The Zyberno Score answers one question: "Is this a quality business worth owning?" It's a 0-100 investment grade that evaluates business fundamentals across four critical dimensions, based on principles from Warren Buffett, Benjamin Graham, Peter Lynch, and Charlie Munger.

The 4 Core Categories (25 points each):

1. PROFITABILITY (25 pts)

Metrics: ROE, ROIC, Net Margin, Operating Margin
Thresholds: ROE >20% excellent • ROIC >20% excellent • Net Margin >20% excellent • Operating Margin >25% excellent

2. FINANCIAL STRENGTH (25 pts)

Metrics: Debt-to-Equity, Current Ratio, Interest Coverage, Altman Z-Score
Thresholds: D/E <0.3 excellent • Current Ratio >2.5 excellent • Interest Coverage >10x excellent • Altman Z >3.0 safe

3. CASH FLOW QUALITY (25 pts)

Metrics: Free Cash Flow, OCF vs Net Income, FCF Margin
Thresholds: Positive & growing FCF excellent • OCF/NI >1.2x excellent (cash earnings exceed accounting)

4. GROWTH & CONSISTENCY (25 pts)

Metrics: Revenue Growth, Net Income Growth, FCF Growth, Piotroski F-Score
Thresholds: Growth via log-linear regression • Piotroski 8-9 excellent, 6-7 good

Score Interpretation:

75-100

GREAT BUSINESS

65-74

GOOD BUSINESS

50-64

AVERAGE BUSINESS

30-49

WEAK BUSINESS

0-29

POOR BUSINESS

→ View full ENOV quality analysis & detailed breakdown

VALUATION SIGNAL

MARGIN OF SAFETY

Is this stock cheap or expensive relative to what the business has historically generated for owners?

-28.3%

Overvalued

Growth gap unavailable — insufficient data for reverse DCF calculation.

🎯 Expected Annual Return →

14.2%

Margin of Safety convergence — your return if the market re-prices to intrinsic value (5-yr annualised)

-17.5%

Yield + growth — what the business alone earns you, even if the market never re-rates

💰 How is Margin of Safety calculated? +

Margin of Safety measures how much discount or premium you're paying relative to a stock's intrinsic value. It's Benjamin Graham's core principle: the larger the margin, the lower your downside risk.

Formula: (Intrinsic Value − Current Price) ÷ Intrinsic Value × 100%

How We Calculate Intrinsic Value (DCF Method):

Step 1: Calculate current Owner Earnings (OCF − Maintenance CapEx)

Step 2: Calculate company-specific growth rate using log-linear regression on 16 quarters of Owner Earnings

Step 3: Project 10 years forward using the calculated growth rate

Step 4: Discount each year's cash flow to present value using 10% discount rate

Step 5: Calculate terminal value using 3% perpetual growth rate

Step 6: Sum all discounted cash flows = Intrinsic Value

What The Percentages Mean:

+50% or more

EXCELLENT — Very undervalued

+25% to +50%

GOOD — Attractive discount

0% to +25%

FAIR — Reasonable value

0% to -25%

CAUTION — Slight premium

-25% or worse

POOR — Overvalued

"Price is what you pay, value is what you get." — Warren Buffett

→ View full ENOV valuation analysis · → View full ENOV Brina Gap analysis

📈 How is Brina Gap calculated? +

Brina Gap measures the difference between the growth a business can fundamentally sustain and the growth the market is already pricing in.

Formula: Fundamental Growth Rate − Market-Implied Growth Rate

The Two Components:

Fundamental Growth Rate = ROIC × Reinvestment Rate

What the business can sustainably grow at based on how much it reinvests and what return it earns on that capital. Grounded in historical financials.

Market-Implied Growth Rate = Reverse DCF

The growth rate the current Enterprise Value implicitly assumes. Calculated by back-solving a 10-year DCF model (10% WACC, 3% terminal growth) until the present value of projected cash flows equals EV.

What The Gap Means:

Gap > +5% Market Underestimates — potential upside

+2% to +5% Slight Underestimate

-2% to +2% Fairly Priced — market consensus matches fundamentals

-5% to -2% Slight Overestimate

Gap < -5% Market Overestimates — price embeds optimism fundamentals don't support

A positive gap (market underestimates) combined with a positive Margin of Safety is the strongest combined signal — the business is both cheap historically and forward economics are stronger than the price suggests.

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-68.1%)

Debt-to-Equity (Solvency Risk):AVERAGE (0.89x)

Operating Margin (Operational Efficiency):CRITICAL (-45.1%)

Return on Capital (Capital Efficiency):CRITICAL (-18.8%)

📊 Valuation Trilogy

Three interconnected metrics for complete valuation analysis

Click any metric for full methodology and detailed analysis

Zyberno's Verdict

Enovis Corp (ENOV) stock report — Zyberno Score 26/100 (POOR BUSINESS), Margin of Safety -28.3%, 14% expected annual return. Full financial analysis on Zyberno.

According to Zyberno's DCF model, Enovis Corp (ENOV) trades at $24.90 against an estimated intrinsic value per share of $19.41 — a -28.3% Margin of Safety based on Owner Earnings of $35.92M TTM, projected at 43.5% growth for 10 years with a 2.5% terminal growth rate. Zyberno's model translates this into a 5-year expected return of 14.2% annually.

Over the trailing twelve months, ENOV generated $35.92M in Owner Earnings. Capital was deployed as follows: $206.92M invested in capital expenditures. Reinvestment rate: 224.4%. Owner Earnings have grown at 43.5% annually over the trailing five years using log-linear regression.

DIVISION I: EXECUTIVE SUMMARY

A. Market Valuation

Market Price & Capitalization (2)

Current Price:24.90

Market Cap:$1.43B

Valuation Multiples (3)

P/B Ratio:0.97x

P/S Ratio:0.62x

Peg Ratio:-999.00x

Enterprise Metrics (3)

Enterprise Value:$2.71B

Ev Ebitda Ratio:9.69x

Pfcf Ratio:39.93x

Price Action & Momentum (3)

12-1 Momentum:

+5.4% (15th pctile)

📈 Click to view full ENOV Momentum analysis →

Momentum Percentile:15 / 100

% of 52-Week High:72.6%

B. Profitability Assessment

Return Metrics (5)

ROE:

-68.1%

📊 Click to view full ENOV ROE analysis →

ROA:-27.8%

Roic:

-18.8%

📊 Click to view full ENOV ROIC analysis →

Reinvestment Rate:224.4%

Fundamental Growth Rate (g):-42.3%

Margin Analysis (3)

Operating Margin Ttm:-45.1%

Net Margin Ttm:-48.0%

Ebitda Margin:12.2%

TTM Performance (3)

Gross Margin Ttm:61.1%

Operating Margin Ttm:-45.1%

Net Margin Ttm:-48.0%

Yield Metrics (3)

Earnings Yield:-$77.51

Owner Earnings Yield:$2.50

Dividend Yield:0.0%

C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

Earnings Surprise (SUE):

+0.50

📊 Click to view full ENOV Earnings Surprise analysis →

EPS Surprise vs Expected:99.0%

Latest Earnings Filed:2026-08-06

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):12.7%

Cash Flow Growth (Linear) (2)

Free Cash Flow Growth Rate (Linear):43.6%

Operating Cash Flow Growth Rate (Linear):47.3%

D. Financial Stability

Liquidity Ratios (3)

Current Ratio:1.98x

Quick Ratio:1.00x

Cash Ratio:0.02x

Leverage Analysis (3)

Debt To Equity Ttm:0.89x

Debt-to-Equity Ratio:0.89x

Debt To Ebitda:4.60x

Coverage Ratios (2)

Interest Coverage Ratio:-33.51x

Times Interest Earned:-33.51

Capital Structure (4)

Working Capital:602,639,000.00

Cash And Cash Equivalents:12,563,000.00

Long Term Debt:$1.25B

Net Debt:$1.27B

DIVISION II: FINANCIAL STATEMENTS ANALYSIS

A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $2.30B

Linear Growth: 12.7%

📊 Click to view full ENOV Revenue analysis & methodology →

Cost Of Revenue Ttm:$893.54M

Profitability Breakdown (2)

Gross profit TTM: $1.40B

Linear Growth: 15.1%

📊 Click to view full ENOV Gross Profit analysis & methodology →

-$1.04B

Bottom Line Performance (3)

-$1.10B

Income Before Tax:-$1.07B

Ebitda Ttm:279,332,000.00

Operating Expenses (5)

Operating Expenses:0.00

R And D Expense:124,323,000.00

Sga Expense:1,080,598,000.00

Income Tax Expense:$30.81M

Interest Expense:33,548,000.00

Expense Ratios (3)

R And D To Revenue Percentage:21.3%

Sga To Revenue Percentage:185.4%

Ebitda Margin:12.2%

B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$3.77B

Current Assets:$1.21B

Ppe Net:527,534,000.00

Goodwill:709,853,000.00

Intangible Assets:$1.15B

Liability Structure (4)

Total Liabilities:2,286,961,000.00

Current Liabilities:612,051,000.00

Long Term Debt:$1.25B

Short Term Debt:$37.39M

Equity & Capital (3)

Equity:$1.48B

Retained Earnings:-$1.48B

Common Stock:133,333,333.00

Working Capital Items (3)

Accounts Receivable:441,846,000.00

Inventory:601,660,000.00

Accounts Payable:194,472,000.00

Special Items (2)

Contract Liabilities:0.00

Stock Based Compensation:8,902,000.00

C. Cash Flow Analysis

Operating Activities (2)

Operating cash flow TTM: $242.84M

Linear Growth: 47.3%

Free cash flow TTM: $35.92M

Linear Growth: 43.6%

📊 Click to view full ENOV Free Cash Flow analysis & methodology →

Investment Activities (2)

Investing Cash Flow:-$53.10M

Capital Expenditures Ttm:206,918,000.00

Financing Activities (3)

Financing Cash Flow:$26.02M

Dividends Paid Ttm:0.00

Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:628,000.00

Long Term Debt Issuance:$0.00

Long Term Debt Repayments:$327.56M

Non-Cash Items (1)

Depreciation Amortization Ttm:1,316,052,000.00

DIVISION III: OPERATIONAL METRICS

A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-19.30

-$19.30

Earnings Per Share Ttm:-$19.13

Revenue & Cash Per Share (3)

Sales Per Share Ttm:39.87

Operating Cash Flow Per Share:$3.77

Fcf Per Share Ttm:0.62

Book Value & Capital (2)

Book Value Per Share:$25.68

Cash Per Share:0.22

Dividend Policy (1)

Dividend Payout Ratio:-999.00x

B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.58x

Working Capital Turnover Ttm:3.81x

Receivables Management (2)

Receivables Turnover Ttm:5.20x

Days Sales Outstanding Ttm:70.22

Inventory Management (2)

Inventory Turnover Ttm:1.49x

Days Inventory Outstanding Ttm:245.77

Payables & Cash Cycle (2)

Days Payable Outstanding:79.44

Cash Conversion Cycle:236.55

C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:40.00

Quality Score:35.00

Market Metrics (2)

Beta:0.00x

Volatility Category:unknown

DIVISION IV: INVESTMENT ANALYSIS

A. Value Investment Framework

Owner Earnings Analysis (3)

Owner earnings TTM: $35.92M

Linear Growth: 43.5%

📊 Click to view full ENOV Owner Earnings analysis & methodology →

Owner Earnings Per Share:$0.62

Owner Earnings Yield:$2.50

Growth Assessment (1)

Owner Earnings Growth Rate:$43.47

Damodaran Growth Analysis (2)

Reinvestment Rate:224.4%

Fundamental Growth Rate (g):-42.3%

Intrinsic Value Models (1)

Intrinsic Value:

$1.12B

📊 Click to view full ENOV DCF valuation →

Margin of Safety (1)

Margin Of Safety:

-28.3%

📊 Click to view full ENOV valuation analysis →

Return Scenarios (2)

Theoretical 5-Year Return:

14.2%

📊 Click to view full ENOV expected return analysis →

Forward Expected Return (Yield + Growth):

-17.5%

📊 Click to view full ENOV expected return analysis →

Investment Assessment (1)

Buffett Assessment:Overvalued

B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):12.7%

Cash Flow Growth Rates (2)

Free Cash Flow Growth Rate (Linear):43.6%

Operating Cash Flow Growth Rate (Linear):47.3%

Other Growth Rates (3)

Gross Profit Growth Rate (Linear):15.1%

Book Value Growth Rate (Linear):-20.7%

Owner Earnings Growth Rate:$43.47

C. Company Profile & Context

Corporate Information (6)

Symbol:ENOV

Company Name:Enovis Corp

Sector:Healthcare

Industry:Medical Devices

Exchange:NYSE

Country:United States

Market Classification (3)

Market Cap Category:N/A

Price Category:medium

Volume Category:N/A

Share Structure (3)

Shares Outstanding:57.60M

Shares Outstanding Basic:57.60M

Shares Outstanding Diluted:57.60M

Data Processing Info (3)

Processing Version:v3.0

Last Updated:2026-08-31 18:43:15 UTC

Data Timestamp:2026-08-31T18:43:15.287958